Status:
COMPLETED
Promoting Clinical Guidelines for Opioid Prescribing
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to understand the optimal sequencing and combination of implementation strategies that specific types of clinics and prescribers need to adopt clinical guidelines for opioid prescribin...
Detailed Description
The proposed study evaluates a sequence and combination of implementation strategies that is tailored to the needs of stakeholders at different levels (health system, clinic, and prescriber). We will ...
Eligibility Criteria
Inclusion
- Clinics will be eligible for the study if they:
- are a primary care clinic (non-pediatric primary care, internal medicine, or family medicine);
- have not received the systems consultation intervention;
- do not explicitly prohibit initiating opioid therapy;
- do not exceed the performance on key measures of guideline concordance (fewer than 80% of long-term opioid patients have treatment agreements and a urine drug screen in the past 12 months)
- Prescribers will be eligible if they:
- are a primary care provider at the clinic;
- are not temporary providers who do not manage stable panels or patients;
- While patients are not subjects of study, de-identified prescriber panel data will be used to assess outcome measures. To be included in the de-identified prescriber panel data, patients must:
- have a primary care provider at the clinic;
- are prescribed opioid therapy for at least 3 consecutive months;
- do not have a cancer diagnosis or are receiving hospice care.
Exclusion
- Clinics will be excluded if they are not a primary care clinic, have received the systems consultation intervention, prohibit initiating opioid therapy, or exceed the threshold on key measures of guideline concordance.
- Prescribers will be excluded if they don't have prescribing privileges or are temporary providers who do not manage stable panels or patients.
- De-identified prescriber panel data will be excluded from outcome measures if they do not have a primary care provider at the clinic, are not prescribed opioid therapy for at least 3 consecutive months, or have a cancer diagnosis or are receiving hospice care.
Key Trial Info
Start Date :
January 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT04044521
Start Date
January 31 2020
End Date
September 1 2022
Last Update
June 17 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bellin Health Systems
Green Bay, Wisconsin, United States, 54305
2
UW Health
Madison, Wisconsin, United States, 53792